Efficacy and Safety of Different Concentrations of Mapracorat Ointment Over 4 Weeks in Atopic Dermatitis (AD)

Double-blind, Randomized, Vehicle-controlled, Multicenter, Multinational, Parallel-group Study of the Efficacy and Safety of Mapracorat Ointment in Three Concentrations Over Max. 4 Weeks in Subjects With Atopic Dermatitis (AD)

The purpose of this study is to evaluate the efficacy and safety of three concentrations of a development drug compared to ointment base (vehicle) in subjects with Atopic Dermatitis (AD).

Inclusion Criteria:

• Signed written informed consent
• Diagnosis of atopic dermatitis according to Hanifin and Rajka Criteria
• Willingness of subject to follow all study procedures
• Willingness to avoid excessive exposure of diseased areas to natural or artificial sunlight

Exclusion Criteria:

• Pregnancy and breast-feeding
• Clinically relevant disease, which could interfere with the study conduct or the evaluation and interpretation of the study results
• Clinically manifested immunosuppressive disorder or known history of malignant disease
• History of relevant drug and/or food allergies